ISPE RWE Task Force update
Almut

Dear ISPE colleagues,

As announced, here is now more detail about ISPE's new RWE Task Force. ISPE has launched this task force to have a formal entity within ISPE to promote the scientific methods, education, and policies related to the development, use, and interpretation of Real-World Data and Real-World Evidence.

More than 165 ISPE members responded to our initial call for volunteers to serve on this task force, which emphasizes the relevance and importance of this topic to our Society. I am impressed by this level of engagement and look forward to seeing the many contributions that all of you will make. Today I am pleased to announce that Wei Zhou and Helga Gardarsdottir have graciously agreed to co-chair this new task force. Together with the ISPE executive committee and considering many members’ suggestions, we have identified 11 subgroups that will tackle either specific tasks (e.g., launch an ISPE RWE website or develop educational programs) or liaise with other scientific or clinical communities (e.g., ISPOR, cancer, devices) to promote pharmacoepidemiologic methods in the RWE world. Each subgroup will coordinate efforts with the relevant ISPE SIG(s), committee(s) or council(s) as needed. Wei and Helga will reach out early next year with more detail on these subgroups, their chairs and a call for participation.

Given the level of engagement of many ISPE members in RWE, we welcome your continued suggestions as we roll out this initiative in the coming year. But before this, I hope that all of you will find time to celebrate with your family and friends in the next couple of weeks and that the New Year will bring many opportunities for all of us to promote use of reason and science locally and globally.

Happy Holidays!

Almut Winterstein, RPh, PhD, FISPE
President
ISPE
5272 River Rd, Ste 500,
Bethesda, MD 20816
www.pharmacoepi.org